Loading... Please wait...

Adicet Bio, Inc. (ACET) Stock Price, News & Analysis

Currency in USD Disclaimer
$1.21 -$0.13 (-9.7%)
$1.21
$1.34
$1.1
$3.77

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company


  • Altman Z Score -0.63
  • Piotroski Score 4.00
  • Grade Buy

Company brief: Adicet Bio, Inc. (ACET)


Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

Company Calendar


  • 09/06/2018
  • 09/21/2018
  • 10/09/2018
  • N/A
  • 08/07/2024
  • N/A

Price Target and Rating


  • $32.50
  • $38.00
  • $27.00
  • N/A
  • Neutral
  • N/A
  • N/A

Profitability


  • -$2.94
  • -0.46
  • -0.46
  • -0.46
  • $-142,658,000

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.


Latest News of ACET

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.


×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.